Recrudescent Heparin-Induced Thrombocytopenia After Therapeutic Plasma Exchange in a Patient Undergoing Thoracic Aortic Replacement.

Authors :: Man L
Yount K
Grazioli A
Padmanabhan A
Thiele R
Maitland HS
Mazzeffi M
Source :: Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2023 Dec; Vol. 37 (12), pp. 2592-2596. Date of Electronic Publication: 2023 Sep 21.
Publication Year :: 2023
Abstract: Competing Interests: Declaration of Competing Interest Dr Mazzeffi previously received consulting fees from Octapharma and Hemosonics. Dr Padmanabhan reports pending/issued patents (Mayo Clinic, Retham Technologies, and Versiti Blood Center of Wisconsin), equity ownership in and serving as an officer of Retham Technologies, and a member of the advisory board of Veralox Therapeutics.

Subjects :: Humans
Heparin adverse effects
Anticoagulants adverse effects
Plasma Exchange
Thrombocytopenia chemically induced
Thrombocytopenia diagnosis

Full Text Access

Tools